$RVMD News and Market Events
Every $RVMD story Market Flux has tracked.
- Last 7 days
- 1 story
- Previous 7 days
- 0 stories
- Latest story
- Related topics
- Healthcare
- Top Story
Dozens of Biotech and Healthcare Companies Present Pipeline and Growth Updates Across Four Major Investor Conferences
On November 10, 2026, a broad cross-section of biotech and healthcare companies presented at four simultaneous investor conferences: the 3rd Annual Guggenheim Healthcare Innovation…
- Market Flux Event
ESMO 2026 Delivers Wave of Oncology Trial Data Including Strong Results in Pancreatic and Lung Cancer
Multiple cancer drug developers presented significant clinical trial data at the European Society for Medical Oncology Congress 2026 in Madrid, with the most closely watched results coming…
- Market Flux Event
Rapport Therapeutics Surges More Than 50% After Bipolar Mania Drug Meets All Trial Goals
Rapport Therapeutics shares jumped more than 50% on October 20 after the company announced that RAP-219 met both primary and secondary endpoints in a Phase 2 trial enrolling 253 adults with…
- Market Flux Event
Revolution Medicines Wins EU Advisory Panel Backing for Pancreatic Cancer Drug Daraxonrasib
Revolution Medicines received a positive opinion from the European Medicines Agency's Committee for Human Medicinal Products on Thursday, recommending marketing authorization in the…
- Market Flux Event
FDA Approves Revolution Medicines Daraxonrasib as First RAS-Blocking Pill for Pancreatic Cancer
Revolution Medicines received FDA approval on August 26 for daraxonrasib, a once-daily oral drug designed to block multiple forms of the RAS protein in patients with previously treated…